GPT and steatosis: The results showed elevated serum levels of ALT and AST and widespread areas of hepatocellular necrosis and steatosis at 48 h in the CCl4-treated group, but significantly reduced serum levels of ALT and AST and the total size of necrosis and steatosis areas in the MSC transplantation group (Figures 6(a) and 6(b)).